• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂诱导的实验性冠状动脉溶栓中肝素的需求量:与尿激酶诱导的冠状动脉溶栓的比较。

Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.

作者信息

Susawa T, Yui Y, Hattori R, Takahashi M, Aoyama T, Takatsu Y, Sakaguchi K, Yui N, Kawai C

出版信息

Jpn Circ J. 1987 Apr;51(4):431-5. doi: 10.1253/jcj.51.431.

DOI:10.1253/jcj.51.431
PMID:2441082
Abstract

The requirement of heparin in experimental coronary thrombolysis induced by tissue-type plasminogen activator (t-PA) was studied in closed-chest dogs with one hour old coronary thrombi and compared with that in urokinase (UK)-induced coronary thrombolysis. Animals were divided into 5 treatment groups as follows: group 1 received intracoronary t-PA alone (1,000 IU/kg/min; n = 5), and if thrombolysis was not induced within 40 to 50 min, dogs then received an intravenous injection of heparin (300 U/kg) plus intracoronary t-PA; group 2 received intravenous heparin at first, and if thrombolysis was not induced within 10 min, dogs subsequently received intracoronary t-PA (n = 5); group 3 also received intravenous heparin at first, and if thrombolysis was not induced within 10 min, dogs subsequently received t-PA but intravenously, as compared with the groups administered by the intracoronary route (n = 6); group 4 received intracoronary UK alone (1,000 IU/kg/min; n = 6); group 5 received intravenous heparin at first, and if thrombolysis was not induced within 10 min, dogs subsequently received intracoronary UK (n = 5). Thrombolysis was confirmed angiographically. In group I, coronary thrombolysis could not be induced within 44 +/- 4 min by intracoronary t-PA alone, but it occurred in 8 +/- 4 min when administered in combination with heparin in all dogs. Heparin alone failed to elicit reperfusion within 10 min in group 2, 3 and 5. t-PA, however, induced successful reperfusion in 16 +/- 5 min (group 2) and in 23 +/- 6 min (group 3), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在患有1小时陈旧性冠状动脉血栓的闭胸犬中,研究了组织型纤溶酶原激活剂(t-PA)诱导的实验性冠状动脉溶栓中肝素的需求情况,并与尿激酶(UK)诱导的冠状动脉溶栓中的情况进行了比较。动物被分为以下5个治疗组:第1组仅接受冠状动脉内注射t-PA(1000 IU/kg/分钟;n = 5),如果在40至50分钟内未诱导出溶栓效果,犬随后接受静脉注射肝素(300 U/kg)加冠状动脉内t-PA;第2组首先接受静脉注射肝素,如果在10分钟内未诱导出溶栓效果,犬随后接受冠状动脉内t-PA(n = 5);第3组也首先接受静脉注射肝素,如果在10分钟内未诱导出溶栓效果,犬随后接受t-PA,但为静脉注射,与冠状动脉内给药组进行比较(n = 6);第4组仅接受冠状动脉内UK(1000 IU/kg/分钟;n = 6);第5组首先接受静脉注射肝素,如果在10分钟内未诱导出溶栓效果,犬随后接受冠状动脉内UK(n = 5)。通过血管造影确认溶栓情况。在第1组中,仅冠状动脉内注射t-PA在44±4分钟内未能诱导出冠状动脉溶栓,但当与肝素联合使用时,所有犬均在8±4分钟内发生了溶栓。在第2、3和5组中,仅肝素在10分钟内未能引起再灌注。然而,t-PA分别在16±5分钟(第2组)和23±6分钟(第3组)诱导出了成功的再灌注。(摘要截短至250字)

相似文献

1
Heparin requirement in tissue-type plasminogen activator-induced experimental coronary thrombolysis: comparison with urokinase-induced coronary thrombolysis.组织型纤溶酶原激活剂诱导的实验性冠状动脉溶栓中肝素的需求量:与尿激酶诱导的冠状动脉溶栓的比较。
Jpn Circ J. 1987 Apr;51(4):431-5. doi: 10.1253/jcj.51.431.
2
Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
Jpn Circ J. 1988 Jan;52(1):72-8. doi: 10.1253/jcj.52.72.
3
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Circulation. 1989 Apr;79(4):911-9. doi: 10.1161/01.cir.79.4.911.
4
Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.
Thromb Res. 1988 Jul 1;51(1):63-74. doi: 10.1016/0049-3848(88)90283-6.
5
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.硝酸甘油联合治疗未能提高组织型纤溶酶原激活剂对冠状动脉血栓形成疗效的病理基础。
Cardiovasc Res. 1991 Apr;25(4):283-9. doi: 10.1093/cvr/25.4.283.
6
A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysis.一种用于研究溶栓后再血栓形成的冠状动脉血栓形成叠加高度狭窄的犬模型。
J Am Coll Cardiol. 1989 May;13(6):1409-14. doi: 10.1016/0735-1097(89)90319-7.
7
Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Circulation. 1988 Mar;77(3):678-84. doi: 10.1161/01.cir.77.3.678.
8
The thrombolytic effects of native tissue-type plasminogen activator (AK-124) on experimental canine coronary thrombosis.天然组织型纤溶酶原激活剂(AK - 124)对实验性犬冠状动脉血栓形成的溶栓作用。
Angiology. 1989 May;40(5):429-35. doi: 10.1177/000331978904000502.
9
Influence of heparin and systemic lysis on coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary thrombosis.
J Am Coll Cardiol. 1993 Sep;22(3):914-20. doi: 10.1016/0735-1097(93)90211-i.
10
Coronary thrombosis/thrombolysis in pigs: effects of heparin, ASA, and the thrombin inhibitor inogatran.猪冠状动脉血栓形成/溶栓:肝素、阿司匹林及凝血酶抑制剂依诺加群的作用
J Pharmacol Toxicol Methods. 1998 Mar;39(2):81-9. doi: 10.1016/s1056-8719(98)00006-9.